conjugated estrogens
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Premarin Intravenous | POWDER FOR INJECTION, INJECTABLE | 25 mg | ||||
| Cenestin, Enjuvia | TABLET, ORAL | synthetic 0.9 mg, synthetic 1.25 mg | ||||
| Cenestin, Enjuvia | TABLET, ORAL | synthetic 0.3 mg, synthetic 0.45 mg, synthetic 0.625 mg | ||||
| Premarin | TABLET, ORAL | 0.3 mg, 0.625 mg, 1.25 mg | ||||
| Premarin | TABLET, ORAL | 0.45 mg, 0.9 mg |
Menest Backorder (June 2023): Menest 0.625 mg tablets are on long term backorder. Premarin 0.625 mg may be dispensed for the duration of the backorder.
Menest permanently discontinued as of late-2025. Utilize Premarin as needed (Pending P&T Review/Update February 2026).
ORDERED FORMULATION
FORMULARY INTERCHANGE
conjugated estrogens (Cenestin, Enjuvia)
esterified estrogens (Menest)
conjugated estrogens (Cenestin, Enjuvia)
conjugated estrogens (Premarin)
conjugated estrogens (Premarin)
esterified estrogens (Menest)
Reviewed: October 25, 2006